Literature DB >> 3240341

Calicheamicin gamma 1I: an antitumor antibiotic that cleaves double-stranded DNA site specifically.

N Zein1, A M Sinha, W J McGahren, G A Ellestad.   

Abstract

Calicheamicin gamma 1I is a recently discovered diyne-ene--containing antitumor antibiotic with considerable potency against murine tumors. In vitro, this drug interacts with double-helical DNA in the minor groove and causes site-specific double-stranded cleavage. It is proposed that the observed cleavage specificity is a result of a unique fit of the drug and DNA followed by the generation of a nondiffusible 1,4-dehydrobenzene--diradical species that initiates oxidative strand scission by hydrogen abstraction on the deoxyribose ring. The ability of calicheamicin gamma 1I to cause double-strand cuts at very low concentrations may account for its potent antitumor activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3240341     DOI: 10.1126/science.3240341

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  86 in total

1.  A continuous assay for DNA cleavage: the application of "break lights" to enediynes, iron-dependent agents, and nucleases.

Authors:  J B Biggins; J R Prudent; D J Marshall; M Ruppen; J S Thorson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Rapid PCR amplification of minimal enediyne polyketide synthase cassettes leads to a predictive familial classification model.

Authors:  Wen Liu; Joachim Ahlert; Qunjie Gao; Evelyn Wendt-Pienkowski; Ben Shen; Jon S Thorson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-03       Impact factor: 11.205

Review 3.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

Review 4.  Novel agents for the treatment of childhood acute leukemia.

Authors:  Colleen E Annesley; Patrick Brown
Journal:  Ther Adv Hematol       Date:  2015-04

5.  Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics.

Authors:  Y Sugiura; Y Uesawa; Y Takahashi; J Kuwahara; J Golik; T W Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Mutations in the P1 promoter region of Micromonospora echinospora.

Authors:  L S Lin; D M Rothstein
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

7.  Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia.

Authors:  Mohammed Gbadamosi; Soheil Meshinchi; Jatinder K Lamba
Journal:  Future Oncol       Date:  2018-07-24       Impact factor: 3.404

8.  Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove.

Authors:  N Ikemoto; R A Kumar; T T Ling; G A Ellestad; S J Danishefsky; D J Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

Review 9.  Recent advances and novel treatment paradigms in acute lymphocytic leukemia.

Authors:  Nikolaos Papadantonakis; Anjali S Advani
Journal:  Ther Adv Hematol       Date:  2016-06-29

10.  Structural characterization of CalO2: a putative orsellinic acid P450 oxidase in the calicheamicin biosynthetic pathway.

Authors:  Jason G McCoy; Heather D Johnson; Shanteri Singh; Craig A Bingman; In-Kyoung Lei; Jon S Thorson; George N Phillips
Journal:  Proteins       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.